Hospice Care

Business

Hims & Hers Bets Big on Super Bowl Ad to Bridge Healthcare Gap and Investor Confidence

In a bold marketing move, telehealth company Hims & Hers is leveraging the Super Bowl's massive audience to spotlight healthcare inequality with its 'Rich People Live Longer' campaign. The push comes as the company expands into advanced diagnostics and treatments, while its stock navigates a significant valuation gap after recent volatility.

Feb 2, 2026

Business

Beyond the Hype: How a Healthcare Real Estate Giant is Quietly Cashing In on the AI Revolution

While tech stocks dominate AI headlines, Welltower Inc. is leveraging artificial intelligence and demographic shifts to redefine senior living and create a powerful growth engine, positioning itself as a unique beneficiary of long-term healthcare trends.

Feb 2, 2026

Business

Maesa's Ontu Launch Aims to Elevate Mass-Market Body Care to Facial-Grade Standards

Brand incubator Maesa is betting on the growing body care category with the launch of Ontu, a new line bringing high-performance, facial-inspired formulas to Target shelves at accessible price points, capitalizing on shifting consumer skincare rituals.

Feb 2, 2026

Business

Arctic Vision Bolsters Global Eye Care Ambitions with Strategic Acquisition of MDCO's Device Unit

Chinese biotech firm Arctic Vision moves to create an integrated ophthalmology powerhouse by acquiring MDCO Technology's device business, combining drug and device expertise to address unmet needs in eye care.

Feb 2, 2026

Business

Wells Fargo Trims UnitedHealth Target by $30, Citing Medicare Advantage Headwinds

Wells Fargo lowered its price target on UnitedHealth Group (UNH) following its Q4 report and a disappointing Medicare rate proposal from regulators, highlighting pressures on the healthcare giant's key growth engine.

Feb 2, 2026

Business

Medicare's Obesity Drug Coverage Set to Fuel Lilly's Weight-Loss Pill Launch, CEO Says

Eli Lilly's CEO sees Medicare's new policy covering obesity treatments as a pivotal moment, poised to unlock access for millions of beneficiaries to its incoming oral drug, orforglipron, and intensify the market battle with Novo Nordisk.

Feb 2, 2026

World

A Nation Preparing for the Inevitable: Zimbabwe's Funeral Insurance Boom Overshadows Healthcare Crisis

In Zimbabwe, where formal employment is scarce and medical costs are prohibitive, a stark financial choice is being made: affordable funeral policies are vastly outpacing health insurance, reflecting a cultural prioritization of dignified burials over accessible healthcare.

Feb 2, 2026

Navigating Medicare's Maze: Three Costly Misconceptions Retirees Must Unlearn

Millions rely on Medicare, yet common misunderstandings about its coverage rules and costs can lead to significant financial shocks in retirement. We clarify three critical areas where assumptions often prove wrong.

Feb 2, 2026

Business

Healthcare Tech Stocks Navigate Turbulent Q3: Omnicell Surges While Peers Stumble

The third-quarter earnings season revealed a stark divergence in performance among leading healthcare technology providers. While Omnicell impressed with strong results and a soaring stock, peers like Evolent Health and Astrana Health faced significant market headwinds despite revenue beats.

Feb 2, 2026

Business

Tandem Diabetes Care: A Value Play After Steep Decline, or Value Trap?

Shares of insulin pump maker Tandem Diabetes Care have plummeted over 80% in five years, trading near $20. A deep dive into valuation metrics suggests the stock may now be modestly undervalued, but significant risks and competitive pressures remain.

Feb 2, 2026

Business

KPJ Healthcare Berhad Sees Accelerating Returns on Capital, Signaling Strategic Growth

The Malaysian healthcare provider KPJ Healthcare Berhad is demonstrating a strengthened capacity for profitable reinvestment, with its return on capital employed rising to 11% alongside significant capital expansion, pointing to a robust operational model.

Feb 2, 2026

Business

Ares Management Doubles Down on Alternative Assets: From Football Clubs to Personal Care Giant

In a strategic push beyond traditional lending, Ares Management has seized operational control of a multi-club football group and orchestrated a $1.6 billion financing to create a new global personal care platform, Evermark. The moves signal the firm's aggressive expansion into high-profile, control-oriented credit opportunities.

Jan 31, 2026

Business

Exclusive: Thoma Bravo Weighs Multi-Billion Dollar Sale of Healthcare Cybersecurity Leader Imprivata

Private equity giant Thoma Bravo is exploring a sale of Imprivata, a key player in healthcare digital identity software, in a deal that could value the company at up to $7 billion, sources tell Reuters.

Jan 30, 2026

Business

Medicare Advantage Squeeze: Are CVS and Humana's Dividend Stocks Now a Buy?

New CMS reimbursement rates are pressuring Medicare Advantage profits, sending shares of Humana and CVS Health lower. We analyze whether the sell-off presents a buying opportunity for dividend investors or signals deeper structural challenges.

Jan 30, 2026

Business

UnitedHealth Maintains Long-Term Growth Outlook Despite Medicare Rate Uncertainty, RBC Says

RBC Capital reaffirms its Outperform rating on UnitedHealth Group, citing management's commitment to long-term earnings targets, even as a lower-than-expected Medicare Advantage rate proposal triggers a sharp sell-off in the health insurer's shares.

Jan 30, 2026

Business

Omega Healthcare Investors Holds Steady on Dividend Amid Sector Scrutiny

Omega Healthcare Investors (OHI) maintains its quarterly dividend, offering a signal of stability to income-focused shareholders as the healthcare REIT navigates tenant health and leverage concerns in a challenging operating environment.

Jan 30, 2026

Business

Truist Trims Price Target on American Healthcare REIT, Maintains Buy Rating Amid Sector Recalibration

Truist Securities adjusted its price target for American Healthcare REIT (NYSE: AHR) downward slightly, while affirming a Buy rating. The move comes as the firm reassesses its outlook for the broader REIT sector heading into 2026.

Jan 30, 2026

Business

Beyond the Hype: Three Healthcare Stocks Facing Headwinds in a Booming Sector

While the healthcare sector has significantly outperformed the broader market, surging 17.4% in six months, not all companies are positioned to thrive. Intense competition and shifting market dynamics pose risks for some established players. We examine three stocks where investors may want to exercise caution.

Jan 30, 2026

Business

Healthcare Sector Outperforms, But Investors Must Navigate Regulatory Crosscurrents

While the healthcare sector has surged 17.4% in six months, outpacing the S&P 500, regulatory headwinds and valuation concerns demand a selective approach. We examine one stock with a durable edge and two facing significant challenges.

Jan 30, 2026

Business

Healthcare's Bull Run: One Stock for the Long Haul, Two to Approach with Caution

The healthcare sector has surged 17.4% in six months, outpacing the S&P 500. While demographic trends fuel long-term growth, regulatory hurdles and valuation concerns demand selective investing. We analyze one company built for decades of returns and two where investors should tread carefully.

Jan 30, 2026